 Spandana Sphoorty Financial Ltd consolidated Q2FY26 loss at Rs. 249.13 crores
Spandana Sphoorty Financial Ltd consolidated Q2FY26 loss at Rs. 249.13 crores Steelcast Ltd posts higher PAT of Rs. 23.21 crores in Q2 FY26
Steelcast Ltd posts higher PAT of Rs. 23.21 crores in Q2 FY26 Schaeffler India Ltd Q3 CY2025 consolidated PAT up at Rs. 289.26 crores
Schaeffler India Ltd Q3 CY2025 consolidated PAT up at Rs. 289.26 crores Tatva Chintan Pharma Chem Ltd consolidated Q2FY26 PAT climbs to Rs. 9.91 crores
Tatva Chintan Pharma Chem Ltd consolidated Q2FY26 PAT climbs to Rs. 9.91 crores GPT Infraprojects Ltd receives contract worth Rs. 37.8 crore
GPT Infraprojects Ltd receives contract worth Rs. 37.8 crore 
              The Right Issue Committee of Director, authorized by board of directors of Sun Pharma Advanced Research Company Ltd, at its meeting on April 27, 2016 from 10:00 am to 10:30 am, has approved the allotment of 1,02,04,081 fully paid-up equity shares of face value of Re. 1 each at a price of Rs. 245 per equity share (including a share premium of Rs. 244 per equity share) issued on a Right basis, to all eligible applicants who have subscribed to the said issue and whose applications were valid.
Shares of SUN PHARMA ADVANCED RESEARCH COMPANY LTD. was last trading in BSE at Rs.308.15 as compared to the previous close of Rs. 303.4. The total number of shares traded during the day was 126582 in over 3893 trades.
The stock hit an intraday high of Rs. 314.05 and intraday low of 305. The net turnover during the day was Rs. 39336334.